Dr. Bertagnolli is a professor of surgical oncology at Harvard Medical School in Boston. She is also chief of the division of surgical oncology at Brigham and Womens’ Hospital and Dana-Farber Cancer Institute, also in Boston.
Dr. Bertagnolli is a former ASCO president. The medical association applauded the president’s pick in a statement.
“An accomplished cancer surgeon and researcher with deep expertise in community-based cancer research, Dr. Bertagnolli has the knowledge, passion and skillset to successfully lead the nation’s top federal cancer research agency and the wider U.S. cancer research. We enthusiastically endorse her selection,” ASCO’s statement said.
The National Cancer Institute supports the nation’s 71 NCI-designated cancer centers in leading research. It funds nearly $7 billion of research each year.
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
